Large or Invasive Pheochromocytoma: What to Do When Initial Preoperative Blockade Has Not Normalized Blood Pressure
In pheochromocytoma with a tumor larger than 6 cm, or in invasive pheochromocytoma, reaching the required preoperative blood pressure and heart rate targets can be challenging. When first-line blockade does not fully achieve those goals, a structured next-step approach is required before surgery can proceed safely.
This protocol applies to patients with a pheochromocytoma larger than 6 cm or with evidence of local invasion. Open surgical resection is recommended in this population to ensure complete tumor removal, prevent tumor rupture, and avoid local recurrence.
The first-line approach — α-adrenergic receptor blockade (phenoxybenzamine or doxazosin), together with high-sodium diet, fluid loading, and β-adrenergic receptor blockers (propranolol or atenolol) for tachycardia control — targets a blood pressure below 130/80 mm Hg while seated (systolic above 90 mm Hg standing) and a heart rate of 60–70 bpm seated, 70–80 bpm standing. This protocol is indicated when those targets have not been achieved.
Adding a calcium channel blocker to the existing α-adrenergic receptor blockade is the central next step for achieving further blood pressure control — additional options are also available for cases that require further stabilization before surgery. The complete treatment algorithm, agent selection, and monitoring guidance are in the full protocol.
Target: blood pressure <130/80 mm Hg seated, systolic >90 mm Hg standing; heart rate 60–70 bpm seated and 70–80 bpm standing.
DOI: 10.1210/jc.2014-1498
- We recommend open resection for large (eg, >6 cm) or invasive pheochromocytomas to ensure complete tumor resection, prevent tumor rupture, and avoid local recurrence.
- Calcium channel blockers are the most often used add-on drug class to further improve blood pressure control in patients already treated with α-adrenergic receptor blockers.
- α-Methyl-paratyrosine (metyrosine) inhibits catecholamine synthesis and may be used in combination with α-adrenergic receptor blockers for a short period before surgery to further stabilize blood pressure to reduce blood loss and volume depletion during surgery.
- Based on retrospective studies and institutional experience, a target blood pressure of less than 130/80 mm Hg while seated and greater than 90 mm Hg systolic while standing seems reasonable, with a target heart rate of 60–70 bpm seated and 70–80 bpm standing.